Desjardins, A., Reardon, D. A., Vredenburgh, J. J., Peters, K., Trikha, M., James, J., … Friedman, H. S. (2011). A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED). Journal of Clinical Oncology, 29(15_suppl), 2070–2070. https://doi.org/10.1200/jco.2011.29.15_suppl.2070

Desjardins, A., D. A. Reardon, J. J. Vredenburgh, K. Peters, M. Trikha, J. James, M. Gardner, A. Brickhouse, J. E. Herndon, and H. S. Friedman. “A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED).” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 2070–2070. https://doi.org/10.1200/jco.2011.29.15_suppl.2070.

Desjardins A, Reardon DA, Vredenburgh JJ, Peters K, Trikha M, James J, et al. A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED). Journal of Clinical Oncology. 2011 May 20;29(15_suppl):2070–2070.

Desjardins, A., et al. “A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED).” Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2011, pp. 2070–2070. Crossref, doi:10.1200/jco.2011.29.15_suppl.2070.

Desjardins A, Reardon DA, Vredenburgh JJ, Peters K, Trikha M, James J, Gardner M, Brickhouse A, Herndon JE, Friedman HS. A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011 May 20;29(15_suppl):2070–2070.